
Indegene Acquires BioPharm to Expand AI-Driven Marketing and AdTech for Global Pharma
Indegene, a tech-native life sciences specialist, announced the strategic acquisition of BioPharm, a Pennsylvania-based specialized marketing services agency. This acquisition strengthens Indegene’s commercialization portfolio with AdTech, combining AI and digital advertising, enabling pharma companies to drive more precise, scalable, and measurable outcomes. The acquisition solidifies Indegene’s position as a true category leader in data-driven Omnichannel and Media Space. BioPharm brings deep expertise in omnichannel strategy, end-to-end media journey, and data-driven campaign execution. The powerful combination of Indegene and BioPharm brings together vast, rich data assets that will drive significantly higher Media ROI and enable more effective Agentic Operations.
Key Highlights
- Indegene acquires BioPharm, a specialized marketing services agency
- Acquisition strengthens Indegene’s commercialization portfolio with AdTech
- Combines AI and digital advertising for more precise, scalable, and measurable outcomes
- BioPharm brings deep expertise in omnichannel strategy and data-driven campaign execution
- Powerful combination of Indegene and BioPharm brings together vast, rich data assets for higher Media ROI and effective Agentic Operations